<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Lohse | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/cobwebname57/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/cobwebname57/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lohse.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">f24a55bce297ab609980fea1b09721b1</guid>
				<title>Lohse posted an update: 7%) and IVF (18.1%). In IUI, the odds ratios (ORs) for [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41962/</link>
				<pubDate>Sat, 08 Feb 2025 11:42:01 -0800</pubDate>

									<content:encoded><![CDATA[<p>7%) and IVF (18.1%). In IUI, the odds ratios (ORs) for pregnancy and live birth were significantly lower for couples in men diagnosed with grades 1 or 2 varicocele as compared to those for men with grade 3 varicocele. In IVF, ORs for live birth where men were diagnosed with grades 1 or 2 varicocele were also lower than those for men with grade&hellip;<span class="activity-read-more" id="activity-read-more-41962"><a href="http://www.nationalboardinstitute.com/activity/p/41962/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a3e3201a08b12c4768786ab1a54a35c1</guid>
				<title>Lohse posted an update: However, there was no effect in the auditory only group. [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38468/</link>
				<pubDate>Tue, 04 Feb 2025 11:39:57 -0800</pubDate>

									<content:encoded><![CDATA[<p>However, there was no effect in the auditory only group. Also, there was no effect in sham group when THI scores were compared with that of the pre-treatment. These results are in line with the former studies that reported a better treatment effect by multiple site rTMS.Chemical analysis of the crude extract of bacterial strain Bacillus&hellip;<span class="activity-read-more" id="activity-read-more-38468"><a href="http://www.nationalboardinstitute.com/activity/p/38468/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">421ba2437c4bba63ef705f6dc7376e3f</guid>
				<title>Lohse posted an update: Soft tissue tumors are diagnostically challenging, and it is [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34822/</link>
				<pubDate>Fri, 31 Jan 2025 11:41:36 -0800</pubDate>

									<content:encoded><![CDATA[<p>Soft tissue tumors are diagnostically challenging, and it is recommended that these are reported or reviewed by specialist soft tissue pathologists. We present our experience with second-opinion (consultation) cases in a specialist tertiary sarcoma center. The aim of this study was to determine areas of diagnostic difficulty in soft tissue&hellip;<span class="activity-read-more" id="activity-read-more-34822"><a href="http://www.nationalboardinstitute.com/activity/p/34822/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4e4b9e95d3820f3531178b24cd237d07</guid>
				<title>Lohse posted an update: Ceftriaxone treatment significantly improved the above [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28811/</link>
				<pubDate>Tue, 28 Jan 2025 11:46:35 -0800</pubDate>

									<content:encoded><![CDATA[<p>Ceftriaxone treatment significantly improved the above impairments in APP/PS1 mice, but had negligible impact in GLT-1</p>
<p> APP/PS1 mice. The xCT expression increased in APP/PS1 and GLT-1</p>
<p> APP/PS1 mice. This upregulation might be a compensatory change against the accumulated glutamate resulting from GLT-1 impairment. Ceftriaxone treatment&hellip;<span class="activity-read-more" id="activity-read-more-28811"><a href="http://www.nationalboardinstitute.com/activity/p/28811/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f89770e22928374de4bbf8699c226b29</guid>
				<title>Lohse became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28719/</link>
				<pubDate>Tue, 28 Jan 2025 11:39:21 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>